Treatment of patients with osteoporosis: issues of therapy duration, adherence, and replacement

Osteoporosis is a chronic disease requiring long-term treatment aimed at reducing the risk of low-energy fractures, by improving the quality and strength of bones when taking this or that drug. Bisphosphonates (BPs) are deposited in the bone, so that they have an aftereffect. Due to the increased ri...

Full description

Bibliographic Details
Main Author: N. V. Toroptsova
Format: Article
Language:Russian
Published: IMA-PRESS LLC 2018-12-01
Series:Современная ревматология
Subjects:
Online Access:https://mrj.ima-press.net/mrj/article/view/863
_version_ 1797876739924295680
author N. V. Toroptsova
author_facet N. V. Toroptsova
author_sort N. V. Toroptsova
collection DOAJ
description Osteoporosis is a chronic disease requiring long-term treatment aimed at reducing the risk of low-energy fractures, by improving the quality and strength of bones when taking this or that drug. Bisphosphonates (BPs) are deposited in the bone, so that they have an aftereffect. Due to the increased risk of adverse reactions with BPs, the author considers that the patients may take a drug holiday or be switched to alternative therapy. Denosumab may be used continuously for years and, unlike BPs, does not require discontinuation. It is effective in both untreated and already BP-treated patients. At the same time, when the treatment is discontinued, the effect of denosumab is reversible; therefore, oral BP or intravenous zoledronic acid is recommended to maintain the achieved effect.
first_indexed 2024-04-10T02:06:14Z
format Article
id doaj.art-4711dc21db1248959523c77f15c729a2
institution Directory Open Access Journal
issn 1996-7012
2310-158X
language Russian
last_indexed 2024-04-10T02:06:14Z
publishDate 2018-12-01
publisher IMA-PRESS LLC
record_format Article
series Современная ревматология
spelling doaj.art-4711dc21db1248959523c77f15c729a22023-03-13T08:39:26ZrusIMA-PRESS LLCСовременная ревматология1996-70122310-158X2018-12-01124596410.14412/1996-7012-2018-4-59-642127Treatment of patients with osteoporosis: issues of therapy duration, adherence, and replacementN. V. Toroptsova0ФГБНУ «Научно-исследовательский институт ревматологии им. В.А. Насоновой».Osteoporosis is a chronic disease requiring long-term treatment aimed at reducing the risk of low-energy fractures, by improving the quality and strength of bones when taking this or that drug. Bisphosphonates (BPs) are deposited in the bone, so that they have an aftereffect. Due to the increased risk of adverse reactions with BPs, the author considers that the patients may take a drug holiday or be switched to alternative therapy. Denosumab may be used continuously for years and, unlike BPs, does not require discontinuation. It is effective in both untreated and already BP-treated patients. At the same time, when the treatment is discontinued, the effect of denosumab is reversible; therefore, oral BP or intravenous zoledronic acid is recommended to maintain the achieved effect.https://mrj.ima-press.net/mrj/article/view/863остеопорозлечениеденосумаббисфосфонатыприверженность лечениюдлительность лечения
spellingShingle N. V. Toroptsova
Treatment of patients with osteoporosis: issues of therapy duration, adherence, and replacement
Современная ревматология
остеопороз
лечение
деносумаб
бисфосфонаты
приверженность лечению
длительность лечения
title Treatment of patients with osteoporosis: issues of therapy duration, adherence, and replacement
title_full Treatment of patients with osteoporosis: issues of therapy duration, adherence, and replacement
title_fullStr Treatment of patients with osteoporosis: issues of therapy duration, adherence, and replacement
title_full_unstemmed Treatment of patients with osteoporosis: issues of therapy duration, adherence, and replacement
title_short Treatment of patients with osteoporosis: issues of therapy duration, adherence, and replacement
title_sort treatment of patients with osteoporosis issues of therapy duration adherence and replacement
topic остеопороз
лечение
деносумаб
бисфосфонаты
приверженность лечению
длительность лечения
url https://mrj.ima-press.net/mrj/article/view/863
work_keys_str_mv AT nvtoroptsova treatmentofpatientswithosteoporosisissuesoftherapydurationadherenceandreplacement